A member of the family which founded Takeda Pharmaceuticals joins a growing number of shareholders who are criticizing the drugmaker’s takeover of Shire.
Kazu Takeda is fighting to overturn the Japanese group’s takeover of Shire, saying the deal would have "disastrous" consequences for the business, reported The NY Times.
The group of shareholders, working under the name Thinking about Takeda’s Bright Future, wants to stop the takeover which will make Takeda a pharma giant, claiming the buy goes against the company's core values.
Takeda received U.S. approval for its $62 billion acquisition of London-listed Shire earlier this summer, setting the stage for the biggest international takeover by a Japanese company in history.
[javascriptSnippet]